Cargando…
Metabolic reprogramming: A novel metabolic model for pulmonary hypertension
Pulmonary arterial hypertension, or PAH, is a condition that is characterized by pulmonary artery pressures above 20 mmHg (at rest). In the treatment of PAH, the pulmonary vascular system is regulated to ensure a diastolic and contraction balance; nevertheless, this treatment does not prevent or rev...
Autores principales: | Liu, Xuhan, Zhang, Liping, Zhang, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458918/ https://www.ncbi.nlm.nih.gov/pubmed/36093148 http://dx.doi.org/10.3389/fcvm.2022.957524 |
Ejemplares similares
-
Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2018) -
Clinical features and metabolic reprogramming of atherosclerotic lesions in patients with chronic thromboembolic pulmonary hypertension
por: Liu, Jixiang, et al.
Publicado: (2022) -
Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure
por: Banerjee, Somanshu, et al.
Publicado: (2022) -
Acute pulmonary embolism with arrhythmia associated with minimal change disease in adults: a case report
por: Rong, Chunyan, et al.
Publicado: (2023) -
Acute pulmonary embolism following corticosteroid administration in acute severe ulcerative colitis with gastrointestinal bleeding: A case report
por: Liu, Xuhan, et al.
Publicado: (2022)